Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831202 · ClinicalTrials.gov registry record · Phase 3
SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
A Phase 3 study of Intracranial Aneurysm, sponsored by Galaxy Therapeutics.
- Active
- Registry status
- Phase 3
- Development phase
- 279
- Enrollment target
- 6
- Study locations
NCT05831202 is a Phase 3 study of Intracranial Aneurysm that is active but no longer recruiting, run by Galaxy Therapeutics. The registered enrollment target is 279 participants, below the 9,176-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 6 study locations across 3 states.
The verdict
NCT05831202, a Phase 3 study of Intracranial Aneurysm, is active but no longer recruiting, sponsored by Galaxy Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 279 participants
- Enrollment target
- 6
- Study locations
Study Summary
To establish the safety and effectiveness of the SEAL™ Saccular Endovascular Aneurysm Lattice system for the treatment of saccular intracranial aneurysms. The data from this study will be used to support a premarket approval (PMA) submission.
Conditions Studied
Interventions
- DEVICE The SEAL™ Saccular Endovascular Aneurysm Lattice System
Study Locations (6)
Illinois
- Endeavor Health - Northwest Community Hospital - Arlington Heights
- Endeavor Health - Evanston Hospital - Evanston
- Endeavor Health- Edward Hospital - Naperville
New York
- NYU Langone Health - New York
- Stony Brook University Hospital - Stony Brook
New Jersey
- The Cooper Health System - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2024-08-06 |
| Est. Completion | 2030-09-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05831202
The ClinicalTrials.gov registry entry for NCT05831202 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,176-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The listed sponsor is Galaxy Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which The SEAL™ Saccular Endovascular Aneurysm Lattice System is the first listed.
NCT05831202 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Illinois, New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05831202 about?
NCT05831202 is a clinical study titled "SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial". To establish the safety and effectiveness of the SEAL™ Saccular Endovascular Aneurysm Lattice system for the treatment of saccular intracranial aneurysms. The data from this study will be used to support a premarket approval (PMA) submission.
What is the current status of trial NCT05831202?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 279 participants. The study started on 2024-08-06. Estimated completion is 2030-09-10.
What conditions does trial NCT05831202 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT05831202?
The interventions under investigation include: The SEAL™ Saccular Endovascular Aneurysm Lattice System (DEVICE).
Who is sponsoring clinical trial NCT05831202?
This trial is sponsored by Galaxy Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05831202 being conducted?
This trial has 6 study locations across Illinois, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
-
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
RECRUITING
-
@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
RECRUITING
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.